Device
NanoKnife System
NanoKnife System is a medical device with 4 clinical trials. Currently 3 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
3(75%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
1
25%
Ph phase_3
2
50%
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution3 total trials
Phase 3Large-scale testing
2(66.7%)
N/ANon-phased studies
1(33.3%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
3
trials recruiting
Total Trials
4
all time
Status Distribution
Active(3)
Completed(1)
Detailed Status
Active, not recruiting2
Recruiting1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
3
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 32 (66.7%)
N/A1 (33.3%)
Trials by Status
recruiting125%
active_not_recruiting250%
completed125%
Recent Activity
3 active trials
Showing 4 of 4
recruitingphase_3
Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate Cancer
NCT07548164
active_not_recruitingphase_3
A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic Cancer
NCT03899636
active_not_recruiting
A Registry Study of NanoKnife IRE for Stage 3 Pancreatic Cancer
NCT03899649
completednot_applicable
A Study of the Use of Irreversible Electroporation in Pancreatic Ductal Cancer
NCT03257150
Clinical Trials (4)
Showing 4 of 4 trials
NCT07548164Phase 3
Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate Cancer
NCT03899636Phase 3
A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic Cancer
NCT03899649
A Registry Study of NanoKnife IRE for Stage 3 Pancreatic Cancer
NCT03257150Not Applicable
A Study of the Use of Irreversible Electroporation in Pancreatic Ductal Cancer
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4